NMPA Approval

Metformin Hydrochloride and Empagliflozin Tablets (Ⅰ)

Approval Number

国药准字H20249711

Company重庆希韦医药科技有限公司

Registration Date

December 6, 2024

Drug Information

Generic Name

二甲双胍恩格列净片(Ⅰ)

Dosage Form

片剂

Strength

每片含盐酸二甲双胍500mg与恩格列净5mg

Drug Type

化学药品

Registration Date

December 6, 2024

Company Information

Applicant Company

Company Name重庆希韦医药科技有限公司

Company Address

重庆市经开区长生桥镇江峡路1号16幢（自编号4-6-3）

Manufacturing Company

Company Name重庆华森制药股份有限公司

Company Address

重庆市荣昌区昌州街道板桥路143号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

二甲双胍恩格列净片(Ⅰ) - NMPA 批准文号 | MedPath